You Checked Your Arms in Good Light. Twice. There Is Nothing There.
Body · The Reading Room · 9 min read · what changed in the skin barrier, why the moisturiser aisle is not an arbitrary choice, and the three versions of this that belong with a doctor
Based on the published research of Anna Nicolaou, PhD, FRSC, Professor of Biological Chemistry in the Division of Pharmacy and Optometry at the University of Manchester, senior author of the 2022 study of menopause and the skin’s ceramide profile. University of Manchester profile · the 2022 study · editorial board, Progress in Lipid Research
An itch with nothing to show for it is not a smaller problem. It is a barrier problem, and the barrier has been measured.
It is the inside of the forearms tonight, and the shins, and a patch on your back you cannot reach without turning sideways in the bathroom.
You have checked in good light. Twice, because the first time you assumed you had missed something. Skin the colour it has always been. No rash, no bite, no dry patch to point at, which somehow makes it harder rather than easier, because a symptom with no evidence is a symptom nobody believes. Including, by about the third week, you.
Perimenopause itchy skin is a real and measurable change, and the reason nobody has explained it to you is not that the explanation is missing. It is that the explanation sits in dermatology and lipid chemistry journals, and the pages written for you stop at the word moisturise.
Informational, not medical advice, and worth taking to your clinician rather than instead of one. This is a reading of published research. We are not clinicians; the findings belong to the researchers named below, and the plain-English version is ours.
The short answer: estrogen holds up three things your skin needs to keep water in, and all three drop in the transition. Collagen goes first and fast: a dermatology review reports a rapid decline after menopause, “with nearly a third lost in the first 5 years.”¹ Sebaceous glands shrink and produce less oil.¹ And the ceramides in the outermost layer change: a 2022 Manchester study found postmenopausal skin held lower levels of ceramides, with shorter average chain length, and that those changes were absent in women taking hormone therapy.² Less ceramide and shorter chains means a leakier barrier, more water lost through it, and nerve endings in dry, under-protected skin that fire without anything visible on the surface. That is why there is nothing to see. The itch is coming from the layer above the part you are looking at.
The skim version
- Collagen: “a rapid decline in skin collagen is seen following menopause, with nearly a third lost in the first 5 years.”¹
- Oil: estrogen is associated with fewer and smaller sebaceous glands and lower skin sebum levels.¹
- Ceramides: in 2022, researchers at Manchester found “post-menopausal stratum corneum contained lower levels of ceramides, with shorter average length; changes that were not evident in the HRT group.”²
- Water loss: estrogen applied to skin reduces transepidermal water loss, so the reviewers note that the low-estrogen state could be implicated in increased water loss and subsequent dermatitis.¹
- Itch is common and under-described: the same review states that “pruritus is also frequently seen in postmenopausal women, commonly with associated xerosis,” which is the clinical term for dry skin.¹
- The honest part: the ceramide study compared 7 premenopausal, 11 postmenopausal and 10 postmenopausal women using hormone therapy.² That is a small study measuring real chemistry, not a trial of anything you can buy.
In this article: Why there is nothing to see · The ceramide finding · Why it is worse at night · What this changes about the cream · When it belongs with a doctor · The one move · Questions women actually ask
Why does perimenopause itchy skin come with no rash?
Because the change is in the barrier, and a barrier does not look like anything.
The outermost layer of skin, the stratum corneum, works the way a brick wall works. The cells are the bricks. The mortar is a mixture of lipids, and ceramides are the largest part of that mixture. Mortar has no colour. When it thins, the wall looks exactly the same from outside and behaves completely differently: water leaves faster, irritants get in more easily, and the nerve endings underneath sit in conditions they did not sit in two years ago.
That is the whole reason for the good-light inspection failing. You were looking for a rash, which is an inflammatory event with a visible surface. What you have is a functional change with no surface at all. Dermatologists measure it rather than look at it, using transepidermal water loss, the rate at which water escapes through the skin.
The 2022 review of menopause and skin disorders by Erin Kamp, Mariha Ashraf, Esra Musbahi and Claudia DeGiovanni of the dermatology department at University Hospitals Sussex sets out the chain of reasoning. Estrogen applied to skin has been shown to reduce that water loss and improve barrier function. So, as the authors put it, “it is possible that the hypo-oestrogenic state could be implicated in increased TEWL and subsequent dermatitis.”¹ Take the estrogen away and the barrier gets leakier. Their review also notes, without fuss, that pruritus is frequently seen in postmenopausal women, usually alongside dry skin. Pruritus is the clinical word for itch.¹
So it is documented. It is simply documented somewhere you were never going to be sent.
What the ceramide study actually measured
This is the part that turns a vague story about dryness into chemistry.
Alexandra Kendall, Anna Nicolaou and colleagues at the University of Manchester took stratum corneum samples from premenopausal women, postmenopausal women, and postmenopausal women using hormone therapy, and ran them through mass spectrometry to profile the ceramides.² They also measured water loss through the skin and serum hormone levels, so the chemistry could be lined up against the hormones rather than assumed.
Two findings matter for the itch on your forearms. Postmenopausal skin held less ceramide overall, and the ceramides it held were shorter. Chain length is not a detail. Long-chain ceramides are the ones that pack tightly and hold the barrier closed, so a shift toward shorter ones means a barrier that leaks more even if the total amount looked respectable. In the researchers’ own words, “post-menopausal stratum corneum contained lower levels of ceramides, with shorter average length; changes that were not evident in the HRT group.”²
And then the line that does the most work. The paper reports that serum estradiol correlated with both how much ceramide was present and how long the chains were.² More estradiol in the blood, more and longer ceramides in the skin. That is the mechanism stated as directly as a study can state it.
What the research found
The study. Kendall AC, Pilkington SM, Wray JR, Newton VL, Griffiths CEM, Bell M, Watson REB, Nicolaou A. “Menopause induces changes to the stratum corneum ceramide profile, which are prevented by hormone replacement therapy.” Scientific Reports, volume 12, article 21715, 2022.²
The finding. Postmenopausal skin held less ceramide, in shorter chain lengths, than premenopausal skin. Those differences were not present in the group using hormone therapy, and serum estradiol correlated with both how much ceramide was present and how long the chains were.²
The limitation: the groups were small, at 7, 11 and 10 women, and the hormone therapy group was not randomised, so women choosing hormone therapy may differ in other ways. The study measured skin chemistry, not itch, and it was not a test of any cream. It tells you what changed. It does not tell you what to buy.
If this is one more thing you have been quietly managing alone, alongside the sleep and the temperature and the week that was hard for no reason, the list is worth seeing in one place. Ten minutes of questions, no advice. Start here.
The source for this piece
Anna Nicolaou, PhD, FRSC
Professor of Biological Chemistry in the Division of Pharmacy and Optometry at the University of Manchester, and a Fellow of the Royal Society of Chemistry. Her work is on bioactive lipids and mass spectrometry-based lipidomics, with particular attention to how ceramides and related lipids behave in skin inflammation and skin disease. She is President-Elect of the International Society for the Study of Fatty Acids and Lipids and sits on the editorial board of Progress in Lipid Research.
What we read: Kendall AC, et al., Scientific Reports, 2022.²
Where to follow her work: University of Manchester research profile · the 2022 study, free full text · Progress in Lipid Research editorial board
Why is the itching worse at night?
Because three ordinary things line up after nine in the evening, and none of them is in your head.
Skin temperature rises as core temperature falls for sleep, and warm skin itches more readily than cool skin. Water loss through a weakened barrier continues all night with nothing added back. And there is nothing else competing for your attention, which is not a trivial point: itch, like tinnitus and like pain, is louder in a quiet room.
Add a hot flush or a night sweat and the sequence gets worse, because sweat evaporating off an under-protected barrier takes more water with it. Women describe this in almost identical words on the forums, usually about feet and shins, usually between ten and two.
Which is also why the thing to change is the timing, not the effort. A barrier cream applied to slightly damp skin straight after an evening shower has a different job to one applied to dry skin at breakfast, and the evening one is the one that has to hold for eight hours.
Perimenopause itchy skin: what the mechanism says about the cream
Everyone tells you to moisturise. Almost nobody tells you why the choice between two tubs at the same price is not arbitrary.
| What the product does | What it addresses | What the mechanism says |
|---|---|---|
| Occlusive, sitting on top: petrolatum-type ointments | Slows water escaping | Directly targets the raised water loss, which is the measured change¹ |
| Barrier-lipid: creams containing ceramides and cholesterol | Supplies the mortar that is depleted | Matches what the 2022 study found had changed, though the study tested skin, not creams² |
| Humectant: glycerin, hyaluronic acid | Pulls water into the outer layer | Useful, but water pulled in leaves again through a leaky barrier unless something holds it |
| Fragranced lotion, whatever is in the bathroom | Feels like doing something | Fragrance is a common contact allergen, and sensitised skin is easier to irritate |
| Hot bath, long shower | Relieves it for ten minutes | Strips more lipid from a layer already short of it |
Read the last column and the reasoning stops being a matter of taste. Two of those rows address the measured change. One helps partly. Two work against it.
The other thing the mechanism explains is why this rarely arrives on its own. The same estrogen decline that thins the skin barrier affects other surfaces that need to stay moist. If your eyes have been gritty by four in the afternoon in the same months, that is not a coincidence, and perimenopausal dry eye deserves a piece of its own rather than a line in this one. There is also a histamine strand to this, which has a real mechanism behind it and a contested diagnosis attached to it, and we have written that one up separately: what is actually established about histamine and your hormones.
When this belongs with a doctor, not a cream
Itch with no rash is usually skin. Occasionally it is the first sign of something internal, and the signs that separate the two are specific. Cholestasis, a slowing of bile flow from the liver, produces itching along with yellowing of the skin or the whites of the eyes, urine that has gone darker, and stools that have gone pale or clay-coloured.³ Cleveland Clinic’s guidance on it is to seek attention promptly when those changes appear, because earlier treatment does better.³
So, plainly. Itch plus any yellowing, dark urine or pale stools is a call this week, not a cream. Itch with unexplained weight loss, night sweats that are new and drenching, or swollen glands needs an appointment. Itch that wakes you every night, or covers your whole body, or is severe, or has not improved with basic care, is on the NHS list of reasons to see a GP rather than wait it out.&sup4; And any itch with a rash that is spreading, blistering or painful is a different problem with a different answer.
The sentence to take with you: “I have had generalised itching with no rash for several weeks. I would like it treated as a symptom worth examining, and I would like to know whether bloods are worth doing to rule out a liver, thyroid or blood cause before we call it hormonal.”
The one move: two minutes, damp skin, after the evening shower
Not a routine. One change of timing, tonight.
After your evening shower, pat rather than rub, leave the skin slightly damp, and put a barrier cream on within about three minutes, while the surface still holds water to trap. Forearms, shins, the flat of the back if you can reach. Lower the shower temperature by whatever amount you will actually tolerate.
That is it. The reason it is the one move and not the fourth item on a list of nine is that it lines up exactly with the measured problem: water is leaving faster than it should, so the intervention is to close the gap at the moment the skin is wettest. Everything else, including which tub, is a refinement.
Give it two weeks before judging. Barrier repair is slow, it is not a sensation you will feel on the first night, and the honest version of this is that most women get it substantially better rather than gone.
Questions women actually ask about this
What does perimenopause itch feel like?
Most often a crawling or prickling itch with nothing visible, on the forearms, shins, back and scalp, worse in the evening and after a hot shower. Some women describe it as insects on the skin, some as the feeling of a wool jumper without the jumper. It usually comes with skin that is drier than it used to be, which dermatologists call xerosis, and the itch and the dryness are the same event.¹
How do you stop hormonal itching?
By treating it as a barrier problem rather than an allergy. That means reducing what strips the barrier: hot water, long showers, soap-based washes and fragrance. Then replacing what has been lost, with an occlusive or ceramide-containing cream on damp skin. Hormone therapy is a conversation with a clinician, not a self-prescription, though it is worth knowing that the ceramide changes were absent in the women using it.²
Why is perimenopause itching worse at night and on the legs?
Skin warms as you prepare for sleep, water continues to leave a weakened barrier, and there is nothing else to attend to. Shins and feet have relatively few sebaceous glands to start with, which is why they tend to be first and worst.
Can hormone therapy help itchy skin?
The 2022 study found the ceramide changes were not present in postmenopausal women taking hormone therapy, and that estradiol levels tracked with how much ceramide was present and how long the chains were.² That is suggestive rather than settled, because the group was small and not randomised, and it is one item among many in a decision that belongs with a clinician who knows your history.
Is itchy skin with no rash ever serious?
Usually not, and occasionally yes, which is why the specific combinations matter. Itch with yellowing skin or eyes, dark urine or pale stools points at the liver and needs prompt attention.³ Itch with unexplained weight loss, drenching night sweats or swollen glands needs checking. Itch that is severe, all over, waking you, or not settling with basic care is on the NHS list of reasons to book an appointment.&sup4;
The one move
Tonight: cooler shower, pat dry, barrier cream on damp skin within three minutes. Forearms, shins, back. Two weeks before you judge it.
And if the itching is one line on a longer list you have never written down anywhere, the whole list is the more useful thing to look at. No advice, no programme, just the document. Start here.
Who else has measured this
Alexandra C. Kendall, PhD, Research Fellow in Pharmacy at the University of Manchester, is first author of the 2022 ceramide study and works on skin lipids and the lipid mediators of barrier function.²
University of Manchester profile · the 2022 study
Rachel E. B. Watson, PhD, Professor in the School of Biological Sciences at the University of Manchester and Head of Division for Musculoskeletal Sciences, is a co-author. Her research is on human ageing with particular reference to skin, including both time-related and environmentally driven change.²
University of Manchester profile
Claudia DeGiovanni, Consultant Dermatologist at University Hospitals Sussex NHS Foundation Trust, is senior author of the three-part 2022 review of menopause and skin in Clinical and Experimental Dermatology, the source for the collagen, sebum and water-loss findings above.¹
NHS consultant profile · the review, Part 2
Christopher E. M. Griffiths is a co-author of the ceramide study and one of the named authors on the Manchester skin research programme that produced it.²
the 2022 study author list
Nothing to see is not the same as nothing happening.
You were looking at the bricks. The change was in the mortar, and it has been measured by people with a mass spectrometer, which is a better outcome than the one you reached at eleven o’clock last night about your own reliability as a witness.
Related reading: the symptom that is missing from the standard lists entirely, which symptoms fade and which quietly get worse, and what the transition is doing to the brain at the same time.
On the researchers. Anna Nicolaou, Alexandra Kendall, Rachel Watson and Christopher Griffiths are cited for the 2022 ceramide study at the University of Manchester. Erin Kamp, Mariha Ashraf, Esra Musbahi and Claudia DeGiovanni are cited for the 2022 dermatology review. None of them is your clinician, and none has written about your skin in particular.
Sourcing, disclosure and disclaimers
This is not medical advice. Blue Leaf Journal publishes general information for a general readership. Nothing here is a diagnosis, a treatment recommendation, or a substitute for care from a clinician who knows your history. Informational, not medical advice: see your clinician.
We are not clinicians. Blue Leaf Journal is an independent publication and its bylines carry no medical or academic credential. We read published research and translate it. The findings belong to the researchers and institutions named and linked above; the plain-English rendering is ours, and so is any error in it.
No affiliation and no endorsement. Blue Leaf Journal is not affiliated with Anna Nicolaou, Alexandra C. Kendall, Rachel E. B. Watson, Christopher E. M. Griffiths, Suzanne M. Pilkington, Jonathan R. Wray, Victoria L. Newton, Mike Bell, Erin Kamp, Mariha Ashraf, Esra Musbahi, Claudia DeGiovanni, the University of Manchester, University Hospitals Sussex NHS Foundation Trust, Cleveland Clinic or the NHS. None of them has reviewed, approved or endorsed this article, and none is responsible for it.
No commercial relationship. Nobody named above paid for or was paid for this coverage. No brand of cream, cleanser or supplement is named, recommended or linked, and there are no affiliate links in this article.
How this was checked. Every figure and quotation above was checked against the cited source on 19 September 2026, and each source is linked below. If you find something we have got wrong, write to norawhitfield@blueleafjournal.com and we will correct it and say that we did.
References
1. Kamp E, Ashraf M, Musbahi E, DeGiovanni C. “Menopause, skin and common dermatoses. Part 2: skin disorders.” Clinical and Experimental Dermatology, 2022;47(12):2117. Oxford Academic
2. Kendall AC, Pilkington SM, Wray JR, Newton VL, Griffiths CEM, Bell M, Watson REB, Nicolaou A. “Menopause induces changes to the stratum corneum ceramide profile, which are prevented by hormone replacement therapy.” Scientific Reports, 2022;12:21715. Free full text · University of Manchester record
3. Cleveland Clinic. “Cholestasis.” my.clevelandclinic.org
4. NHS. “Itchy skin.” nhs.uk
If you read one thing after this, read the piece on how long the transition actually runs, because the honest answer to how long the itching lasts is buried inside the honest answer to that.
Nora Whitfield writes for Blue Leaf Journal, where the working rule is that a mechanism you can name is easier to live with than one you cannot. She reads the limitations section before the conclusion, and passes on what she finds there.
Written by Nora Whitfield for Blue Leaf Journal. Updated: 19 September 2026.
